X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

VXRT

Closed

Vaxart Inc

0.6196
+0.0163 (+2.70%)
Last Update: 21 Dec 2024 00:18:00
Yesterday: 0.6033
Day's Range: 0.59 - 0.6399
Send
When Written:
 
0.6089
Vaxart Inc. is a clinical-stage biotechnology company that develops oral vaccines to prevent infectious diseases. The company's proprietary oral vaccine platform uses a recombinant adenovirus technology to deliver vaccine antigens to the immune system. Vaxart's vaccines are designed to provide broad protection against multiple strains of a virus, including emerging variants.

The company's lead product candidate is an oral tablet vaccine for COVID-19, which is currently in Phase II clinical trials. Vaxart also has vaccine candidates in development for influenza, norovirus, and respiratory syncytial virus (RSV).

Vaxart was founded in 2004 and is headquartered in South San Francisco, California. The company went public in 2019 and is traded on the NASDAQ under the ticker symbol VXRT.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:18.216.156.226
X